Education
About Us
Working with TipRanks
Follow Us
AcouSort AB (DE:4SA)
:4SA
4SA Stock Chart & Stats
Day’s Range― - ―
52-Week Range€0.20 - €1.68
Previous CloseN/A
Volume0.00
Average Volume (3M)0.00
Market Cap
€5.97M
Enterprise Value€62.16M
Total Cash (Recent Filing)€3.45M
Total Debt (Recent Filing)kr0.00
Price to Earnings (P/E)―
Beta-0.41
Next Earnings
Aug 27, 2025EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.02
Shares Outstanding21,163,902
10 Day Avg. Volume0
30 Day Avg. Volume0
Financial Highlights & Ratios
PEG Ratio1.52
Price to Book (P/B)9.51
Price to Sales (P/S)0.00
P/FCF Ratio-3.83
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
4SA FAQ
What was AcouSort AB’s price range in the past 12 months?
AcouSort AB lowest stock price was €0.20 and its highest was €1.68 in the past 12 months.
What is AcouSort AB’s market cap?
AcouSort AB’s market cap is €5.97M.
When is AcouSort AB’s upcoming earnings report date?
AcouSort AB’s upcoming earnings report date is Aug 27, 2025 which is in 38 days.
How were AcouSort AB’s earnings last quarter?
Currently, no data Available
Is AcouSort AB overvalued?
According to Wall Street analysts AcouSort AB’s price is currently Overvalued.
Does AcouSort AB pay dividends?
AcouSort AB does not currently pay dividends.
What is AcouSort AB’s EPS estimate?
AcouSort AB’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does AcouSort AB have?
AcouSort AB has 21,163,902 shares outstanding.
What happened to AcouSort AB’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of AcouSort AB?
Currently, no hedge funds are holding shares in DE:4SA
Company Description
AcouSort AB
AcouSort AB (publ), a technology company, develops products and solutions for automated preparation of biological samples based on acoustofluidics technology for researchers and life science companies. It offers AcouTrap, a benchtop research instrument for sample preparation of cells, extracellular vesicles, bacteria, and viruses from various media; AcouPlasma, an integrated blood plasma separation module that enables in-line analysis of blood plasma from whole blood samples; and AcouWash, a benchtop research instrument for label-free separation of target cells from various samples. The company was founded in 2010 and is based in Lund, Sweden.
Technical Analysis
LIDDS AB
―
Modus Therapeutics Holding AB
―
ExpreS2ion Biotech Holding AB
―
CombiGene AB
―
Sprint Bioscience AB
―